Isoniazid preventive therapy use among patients on antiretroviral therapy: A missed opportunity

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 3, 2014, Pages 312-314

  Kufa, T ^a,b   Chihota, V N ^a,b   Charalambous, S ^a,b   Churchyard, G J ^a,b  

^a AURUM INSTITUTE   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

ART; HIV; Isoniazid; TB

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ISONIAZID; TUBERCULOSTATIC AGENT;

ADULT; CD4 LYMPHOCYTE COUNT; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; FEMALE; HEALTH CARE DELIVERY; HIV INFECTIONS; HUMAN; INCIDENCE; MALE; MIXED INFECTION; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; SOUTH AFRICA; STATISTICAL MODEL; TUBERCULOSIS;

ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; COINFECTION; DELIVERY OF HEALTH CARE; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; ISONIAZID; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS;

EID: 84894265948     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0505     Document Type: Article

References (10)

1. Golub J E, Saraceni V, Cavalcante S C, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007; 21: 1441-1448.
2. Golub J E, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS 2009; 23: 631-636.
3. Samandari T, Agizew T B, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, doubleblind, placebo-controlled trial. Lancet 2011; 377: 1588-1598.
4. Rangaka M X, Boulle A, Wilkinson R J, et al. Randomized controlled trial of isoniazid preventive therapy in HIV-infected persons on antiretroviral therapy. Washington DC, USA: XIX International AIDS Conference, 2012. JIAS 2012; 15: 49-50.
5. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: WHO, 2011.
6. Department of Health, Republic of South Africa. Guidelines for tuberculosis preventive therapy among HIV-infected individuals in South Africa. Pretoria, South Africa: Department of Health, 2010.
7. Chehab J C, Vilakazi-Nhlapo K, Vranken P, Peters A, Klausner J D. Survey of isoniazid preventive therapy in South Africa, 2011. Int J Tuberc Lung Dis 2012; 16: 903-907.
8. Department of Heath, Republic of South Africa. The South African antiretroviral treatment guidelines, 2013. Pretoria, South Africa: Department of Health, 2013.
9. Durovni B, Cavalcante S C, Saraceni V, et al. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) Study. AIDS 2010; (Suppl): S49-S56.
10. Mosimaneotsile B, Mathoma A, Chengeta B, et al. Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana experience, 2004-2006. J Acquir Defic Syndr 2010; 54: 71-77. Partnership